BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12411406)

  • 1. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats.
    Chiarugi A
    Br J Pharmacol; 2002 Nov; 137(6):761-70. PubMed ID: 12411406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
    Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
    Zhang Z; Zhang ZY; Wu Y; Schluesener HJ
    Neuroscience; 2012 Sep; 221():140-50. PubMed ID: 22800566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
    Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
    J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders.
    Chiarugi A; Moskowitz MA
    J Neurochem; 2003 Apr; 85(2):306-17. PubMed ID: 12675907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells.
    Nakajima H; Nagaso H; Kakui N; Ishikawa M; Hiranuma T; Hoshiko S
    J Biol Chem; 2004 Oct; 279(41):42774-86. PubMed ID: 15302869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.
    Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE
    Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
    Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
    J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.
    Cavone L; Aldinucci A; Ballerini C; Biagioli T; Moroni F; Chiarugi A
    Mult Scler; 2011 Jul; 17(7):794-807. PubMed ID: 21343230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone.
    Holl V; Coelho D; Weltin D; Hyun JW; Dufour P; Bischoff P
    Anticancer Res; 2000; 20(5A):3233-41. PubMed ID: 11062748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neither energy collapse nor transcription underlie in vitro neurotoxicity of poly(ADP-ribose) polymerase hyper-activation.
    Fossati S; Cipriani G; Moroni F; Chiarugi A
    Neurochem Int; 2007 Jan; 50(1):203-10. PubMed ID: 17052800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase.
    Koedel U; Winkler F; Angele B; Fontana A; Pfister HW
    J Cereb Blood Flow Metab; 2002 Jan; 22(1):39-49. PubMed ID: 11807392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxynitrite and hydrogen peroxide induced cell death in the NSC34 neuroblastoma x spinal cord cell line: role of poly (ADP-ribose) polymerase.
    Cookson MR; Ince PG; Shaw PJ
    J Neurochem; 1998 Feb; 70(2):501-8. PubMed ID: 9453543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma.
    Boulares AH; Zoltoski AJ; Sherif ZA; Jolly P; Massaro D; Smulson ME
    Am J Respir Cell Mol Biol; 2003 Mar; 28(3):322-9. PubMed ID: 12594058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms.
    Dutra RC; de Souza PR; Bento AF; Marcon R; Bicca MA; Pianowski LF; Calixto JB
    Biochem Pharmacol; 2012 Feb; 83(4):531-42. PubMed ID: 22155310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylthioadenosine reverses brain autoimmune disease.
    Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
    Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.